Sonoma Pharmaceuticals Stock (NASDAQ: SNOA)

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock, Quote.Headers.trade-ideas

Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

News

Stock Split

SNOA

Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split.

Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving

movers image

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADAP

AILE

AIMD

ANTE

CMAX

ESPR

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

HUMA

LGMK

MMAT

NDRA

PSIG

TNON

YMAB

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket

Intraday Update

APLD

ATPC

AVAH

CRWD

DOGZ

EMBC

FTEL

KARO

LGCB

LPSN

MEDS

MEIP

MIRA

MNSO

NCPL

NUKK

NWGL

PRTG

RYAAY

SAVA

SERV

SLNA

SLRX

SOPA

TELL

TKNO

VIRI

XCUR

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals Inc

Bright Green Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGXX#NASDAQ">BGXX</a>) <a href="https://www.globenewswire.com/en/news-release/2024/09/19/2949354/0/en/Bright-Green-Corporation-Provides-an-Update-Reinforces-Commitment-to-Shareholders-and-Focuses-on-Growth-and-Strategic-Partnerships.html">announced</a> on Monday that trading of its shares has been suspended from the Nasdaq Stock Exchange, following the cancellation of a scheduled September 26 delisting appeal hearing. No more details were provided at the time of the writing of this article. 
The company confirmed it will move forward with its annual shareholder meeting, scheduled for November 15, 2024. Key agenda items include a proposal for a reverse stock split aimed at increasing shareholder value and positioning Bright Green for a stronger future.
In parallel, the company is actively exploring strategic alternatives, including potential partnerships and acquisitions. These moves reflect a clear focus on fortifying its financial position and expanding its market presence.
<h3 class="wp-block-heading">Commitment To Shareholders And Strategic Focus</h3>
Lynn Stockwell, Chairwoman of the Board, expressed the company's unwavering dedication: "We have provided a line of credit to ensure the Company has the necessary financial resources to support its ongoing operations and strategic initiatives and have agreed to provide $2.5 million in funding." This financial support, she noted, gives the company flexibility to navigate challenges while pursuing growth opportunities.
CEO Groovy Singh also reiterated the company&#8217;s commitment, stating, &#8220;We remain confident in our vision and strategy for the future of Bright Green, including the success of our EB-5 capital raise program.&#8221; Singh acknowledged the obstacles faced by the program due to U.S. government-related delays but reaffirmed the company's focus on licensing approvals and its broader mission of enhancing national security interests through the production of <a href="https://www.benzinga.com/topic/federal-schedule-i">Schedule I</a> and II plant-based medicines.
<h3 class="wp-block-heading">Looking Ahead: Partnerships And Growth</h3>
As part of its plan, Bright Green is considering various options for sustainable financing, including forming strategic partnerships and exploring acquisitions. The company&#8217;s management team remains focused on achieving its long-term vision while continuing to build its operational and financial foundation. Updates on these initiatives are expected in the coming months, and shareholders will have an opportunity to engage in critical discussions at the November meeting.
Cover image made with AI

Cannabis

Psychedelics

Press Releases

BGXX

Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growth

Cantor Fitzgerald analyst Ross Osborn reiterates Nano X Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>) with a Overweight and maintains $14 price target.

Price Target

Reiteration

Analyst Ratings

NNOX

Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $14 Price Target

<a href="https://www.trade.gov/final-determinations-ad-and-cvd-investigations-aluminum-lithographic-printing-plates-china-and" title="https://www.trade.gov/final-determinations-ad-and-cvd-investigations-aluminum-lithographic-printing-plates-china-and">https://www.trade.gov/final-determinations-ad-and-cvd-investigations-aluminum-lithographic-printing-plates-china-and</a>

Legal

Global

KODK

'Final Determinations In The Antidumping Duty And Countervailing Duty Investigations Of Aluminum Lithographic Printing Plates From The People's Republic Of China And Japan' - Trade Administration; The Petitioner Is Eastman Kodak Company, Shares See A Pop In Volume To The Upside

Melius Research analyst Karen Short initiates coverage on Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) with a Hold rating and announces Price Target of $19.

Initiation

Melius Research Initiates Coverage On Albertsons Companies with Hold Rating, Announces Price Target of $19

Investors with a lot of money to spend have taken a bearish stance on United Rentals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with URI, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 12 uncommon options trades for United Rentals.
This isn't normal.
The overall sentiment of these big-money traders is split between 33% bullish and 50%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $353,700, and 8 are calls, for a total amount of $399,909.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $690.0 to $900.0 for United Rentals during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for United Rentals options trades today is 21.86 with a total volume of 342.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for United Rentals's big money trades within a strike price range of $690.0 to $900.0 over the last 30 days.
<h3>United Rentals Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727112652_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>URI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$15.8</td>
<td>$13.3</td>
<td>$15.8</td>
<td>$770.00</td>
<td>$188.0K</td>
<td style="text-align: right;">17</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>URI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$85.4</td>
<td>$84.5</td>
<td>$84.5</td>
<td>$840.00</td>
<td>$67.6K</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">8</td>
</tr>
<tr>
<td>URI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$41.1</td>
<td>$39.8</td>
<td>$41.1</td>
<td>$820.00</td>
<td>$65.4K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">73</td>
</tr>
<tr>
<td>URI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$60.9</td>
<td>$59.0</td>
<td>$60.95</td>
<td>$900.00</td>
<td>$60.9K</td>
<td style="text-align: right;">74</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>URI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$63.0</td>
<td>$59.5</td>
<td>$60.74</td>
<td>$900.00</td>
<td>$60.7K</td>
<td style="text-align: right;">74</td>
<td style="text-align: right;">51</td>
</tr>
</tbody>
</table>

<h3>About United Rentals</h3>
United Rentals is the world's largest equipment rental company. It principally operates in the United States and Canada, where it commands approximately 15% share in a highly fragmented market. It serves three end markets: general industrial, commercial construction, and residential construction. Like its peers, United Rentals historically has provided its customers with equipment that was intermittently used, such as aerial equipment and portable generators. As the company has grown organically and through hundreds of acquisitions since it went public in 1997, its catalog (fleet size of $21 billion) now includes a range of specialty equipment and other items that can be rented for indefinite periods.
After a thorough review of the options trading surrounding United Rentals, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of United Rentals</h3>
<ul>
<li>With a volume of 96,527, the price of URI is up 1.41% at $794.66. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 30 days.</li>
</ul>
<h3>What The Experts Say On United Rentals</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $940.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on United Rentals with a target price of $940. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for United Rentals, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

A Closer Look at United Rentals's Options Market Dynamics

High-rolling investors have positioned themselves bearish on Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SAVA often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for Cassava Sciences. This is not a typical pattern.
The sentiment among these major traders is split, with 37% bullish and 62% bearish. Among all the options we identified, there was one put, amounting to $98,750, and 7 calls, totaling $275,738.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $60.0 for Cassava Sciences over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Cassava Sciences's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Cassava Sciences's significant trades, within a strike price range of $10.0 to $60.0, over the past month.
<h3>Cassava Sciences Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727112647_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.0</td>
<td>$3.95</td>
<td>$3.95</td>
<td>$10.00</td>
<td>$98.7K</td>
<td>12.7K</td>
<td style="text-align: right;">295</td>
</tr>
<tr>
<td>SAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.0</td>
<td>$10.7</td>
<td>$11.0</td>
<td>$60.00</td>
<td>$55.0K</td>
<td>755</td>
<td style="text-align: right;">84</td>
</tr>
<tr>
<td>SAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$10.75</td>
<td>$9.7</td>
<td>$10.1</td>
<td>$40.00</td>
<td>$50.5K</td>
<td>390</td>
<td style="text-align: right;">53</td>
</tr>
<tr>
<td>SAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$11.6</td>
<td>$10.6</td>
<td>$10.8</td>
<td>$35.00</td>
<td>$49.6K</td>
<td>4.3K</td>
<td style="text-align: right;">76</td>
</tr>
<tr>
<td>SAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.9</td>
<td>$6.9</td>
<td>$6.94</td>
<td>$60.00</td>
<td>$34.7K</td>
<td>1.4K</td>
<td style="text-align: right;">62</td>
</tr>
</tbody>
</table>

<h3>About Cassava Sciences</h3>
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Following our analysis of the options activities associated with Cassava Sciences, we pivot to a closer look at the company's own performance.
<h3>Current Position of Cassava Sciences</h3>
<ul>
<li>Currently trading with a volume of 1,372,927, the SAVA's price is down by -10.7%, now at $26.59. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 43 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cassava Sciences options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Cassava Sciences Unusual Options Activity For September 23

High-rolling investors have positioned themselves bullish on On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in ONON often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 29 options trades for On Holding. This is not a typical pattern.
The sentiment among these major traders is split, with 51% bullish and 34% bearish. Among all the options we identified, there was one put, amounting to $126,351, and 28 calls, totaling $1,330,891.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $25.0 to $60.0 for On Holding over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in On Holding's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to On Holding's substantial trades, within a strike price spectrum from $25.0 to $60.0 over the preceding 30 days.
<h3>On Holding 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727112640_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$13.05</td>
<td>$12.85</td>
<td>$13.05</td>
<td>$55.00</td>
<td>$140.9K</td>
<td style="text-align: right;">776</td>
<td style="text-align: right;">784</td>
</tr>
<tr>
<td>ONON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$3.1</td>
<td>$2.95</td>
<td>$2.97</td>
<td>$52.50</td>
<td>$126.3K</td>
<td style="text-align: right;">605</td>
<td style="text-align: right;">426</td>
</tr>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$15.25</td>
<td>$12.85</td>
<td>$13.05</td>
<td>$55.00</td>
<td>$99.4K</td>
<td style="text-align: right;">776</td>
<td style="text-align: right;">674</td>
</tr>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$2.3</td>
<td>$2.28</td>
<td>$2.28</td>
<td>$55.00</td>
<td>$68.3K</td>
<td style="text-align: right;">718</td>
<td style="text-align: right;">422</td>
</tr>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$15.35</td>
<td>$12.85</td>
<td>$12.85</td>
<td>$55.00</td>
<td>$68.0K</td>
<td style="text-align: right;">776</td>
<td style="text-align: right;">497</td>
</tr>
</tbody>
</table>

<h3>About On Holding</h3>
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa, and Asia-Pacific region.
After a thorough review of the options trading surrounding On Holding, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of On Holding</h3>
<ul>
<li>With a trading volume of 2,098,886, the price of ONON is up by 1.98%, reaching $50.94.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 50 days from now.</li>
</ul>
<h3>What The Experts Say On On Holding</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $55.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on On Holding with a target price of $59. 
&#x2A; An analyst from HSBC has revised its rating downward to Hold, adjusting the price target to $52. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for On Holding, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ONON

On Holding Options Trading: A Deep Dive into Market Sentiment

WIIM

MKFG

Markforged Holding shares are trading higher after the company announced that it has entered into a Settlement and Patent License Agreement in connection with the patent infringement litigation brought by Continuous Composites.

Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) has outperformed the market over the past 5 years by 9.08% on an annualized basis producing an average annual return of 23.07%. Currently, Cencora has a market capitalization of $44.71 billion. 
Buying $1000 In COR: If an investor had bought $1000 of COR stock 5 years ago, it would be worth $2,786.77 today based on a price of $228.11 for COR at the time of writing.
<h3>Cencora's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727112615_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today

Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) has outperformed the market over the past 5 years by 5.52% on an annualized basis producing an average annual return of 19.51%. Currently, Intuit has a market capitalization of $179.40 billion. 
Buying $100 In INTU: If an investor had bought $100 of INTU stock 5 years ago, it would be worth $237.93 today based on a price of $641.74 for INTU at the time of writing.
<h3>Intuit's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727112610_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INTU

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

Warner Bros. Discovery (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wbd#NASDAQ">WBD</a>) is one of the world&#39;s biggest names when it comes to entertainment. Although it has overall been a bad year for the company&#39;s stock price, positive news has allowed shares to recover.
On September 12th, the company announced a multi-year deal with one of the largest U.S. cable TV companies, Charter Communications (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chtr#NASDAQ">CHTR</a>), also known as Spectrum. Since the announcement, shares have been up 21%. Let&#39;s dive deeper into what the announcement means for Warner Bros.&#39;s long-term future&nbsp;and whether it can further reignite its shares.
<h2>Breaking Down Warner and Charter&#39;s Big Deal</h2>
The first notable point to make about the deal was that it was reached &quot;nearly one year early.&quot; This shows the two firms understand the need to move quickly in this space. Nielsen data shows that, in June, streaming hit a record market share in TV viewing.
Of the total time spent watching TV, 40.3% was through streaming services, an increase from 37.7% in Jun. 2023. Streaming increased its share mostly by taking from cable providers, whose share went from 30.6% to 27.2%.
Clearly, cable still has a place in the TV market, but it is slowly dying. One good thing about the deal between Warner and Charter is that it focuses on both cable and streaming. This allows the firms to look toward the future with streaming while also maintaining a solid base of customers who still prefer cable.
The deal gives Spectrum customers the ad-supported versions of Warner&#39;s HBO Max and Discovery+ streaming services at no extra charge. It also maintains the availability of Warner&#39;s cable channels like TNT, CNN, and the Food Network. Warner will be receiving higher fees going forward for all its cable channels except for TNT. Management actually saw the lack of a fee cut for TNT as a win since the network lost its rights to broadcast NBA games.
This is key as its &quot;networks&quot; segment is its largest revenue stream and most profitable segment. The network segment&#39;s 43% earnings before interest, taxes, depreciation, and amortization (EBITDA) margin over the last twelve months is strong. It far exceeds the streaming segment&#39;s figure by less than one percent.
Charter is planning to fully launch its direct-to-consumer (DTC) distribution to its cable customers in 2025. This could allow Warner to increase its subscribers by tapping into Charter&#39;s cable customers. HBO Max will be a &quot;preferred partner&quot; for Charter, presumably putting the app in the spotlight when it comes to marketing its DTC platform.
<h2>Taking the Good With the Bad</h2>
There are reasons to be excited, and reasons to not be so excited, about the deal. Charter reached a similar deal with Walt Disney Co.&nbsp;to carry the firm&#39;s ad-supported Disney+ service at no extra cost in January. Yet, reportedly only 10% of Charter&#39;s Select TV customers have signed up for the offer after it has been available for over six months.
This shows either a significant lack of interest from Charter&#39;s customer base and/or its lack of marketing of the product. However, it is apparently fixing issues that may have contributed to the lack of uptake. As Charter irons out problems with the service, Warner should benefit from Disney&#39;s use as a guinea pig.
Still, Charter is losing cable subscribers, making the deal less beneficial to Warner the more those losses continue. It lost 408,000 cable subscribers in Q2, a loss that more than doubled from the same period last year. For Warner and Charter&#39;s sake, hopefully the further inclusion of streaming services in cable packages can help stem these losses.
<h2>A Likely Step in the Right Direction, But Not Proven Yet</h2>
Overall, it feels too early to say that this deal will fully reignite Warner Bros.&#39;s shares. The increased fees for TV networks should help bolster profitability in that area, creating some stability. However, Warner&#39;s streaming services must boost their profits. Their EBITDA fluctuates between slightly positive and slightly negative each quarter.
The deal should help with that immediately, as the company can leverage Charter&#39;s reach and marketing efforts. Disney saw its streaming service have its first profitable quarter in the same quarter its agreement with Charter began.
However, these streaming businesses will need to demonstrate stronger uptake to prove these deals are driving significant growth.
The article &quot;<a href="https://www.nasdaq.com/articles/warner-bross-new-deal-spark-it-needs-reignite-shares">Is Warner Bros.&#39;s New Deal the Spark It Needs to Reignite Shares?</a>&quot; first appeared on MarketBeat.

Earnings

Entertainment

Large Cap

Management

General

CHTR

Is Warner Bros.'s New Deal the Spark It Needs to Reignite Shares?

Oppenheimer analyst Leland Gershell reiterates Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) with a Outperform and maintains $15 price target.

CAPR

Oppenheimer Reiterates Outperform on Capricor Therapeutics, Maintains $15 Price Target

Melius Research analyst Karen Short initiates coverage on Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) with a Hold rating and announces Price Target of $55.

Melius Research Initiates Coverage On Kroger with Hold Rating, Announces Price Target of $55

B of A Securities analyst Lucy Yu downgrades MINISO Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) from Buy to Underperform.

Downgrades

B of A Securities Downgrades MINISO Group Holding to Underperform

<h4>Key Takeaways:</h4>
<ul>
<li>Transsion&rsquo;s CFO was detained early this month and later released, though investors remain wary due to the company&rsquo;s thin profit margins and ongoing legal disputes</li>
<li>The smartphone maker&rsquo;s revenue rose 38% to 34.6 billion yuan in the first half of this year, with 35.7% profit growth, mostly on its expansion into new markets</li>
</ul>
By Hugh Chen
It&rsquo;s known as the &ldquo;King of Africa&rdquo; for its status as the continent&rsquo;s leading smartphone maker. But a recent drama involving&nbsp;Transsion Holdings&nbsp;(688036.SH) has move the spotlight back to the company&rsquo;s home base in China.
The tense times began around two weeks ago, when CFO Xiao Yonghui was detained on suspicion of unspecified illegal activity,&nbsp;<a href="http://www.sse.com.cn/disclosure/listedinfo/announcement/c/new/2024-09-07/688036_20240907_RYQN.pdf">the company said</a>&nbsp;in a statement dated Sept. 7. But the drama abruptly ended last week when Transsion provided&nbsp;<a href="http://www.sse.com.cn/disclosure/listedinfo/announcement/c/new/2024-09-18/688036_20240918_VIJF.pdf">an update</a>&nbsp;saying Xiao had been released and resumed his duties as CFO.
Such disappearances aren&rsquo;t unheard of in China, and usually occur when company officials are suspected of wrongdoing or are assisting in investigations of other people suspected of crimes. Gaming company DouYu (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/doyu#NASDAQ">DOYU</a>) and private equity firm China Renaissance (1911.HK) have each lost their top executives to such circumstances over the last two years, with devastating consequences for their stocks.
While both executives remain out of sight, and DouYu&rsquo;s has been charged with a crime, Transsion appears to have dodged a bullet with Xiao&rsquo;s release. Still, the crisis has taken some of the momentum away from company&rsquo;s rapid rise that saw it break into the top five global smartphone makers last year as it expanded beyond its African base.
There&rsquo;s always the potential for future investigations, and Transsion is facing separate headaches from other legal disputes over intellectual property rights and intensifying competition. Both Chinese and international rivals are now vying for market share not only in Transsion&rsquo;s African stronghold, but also in new markets like Latin America, where the company has been expanding.
In its Sept. 7 statement, when Transsion first disclosed Xiao&rsquo;s detention, the company assured investors that &ldquo;current production, operations, and management remain normal,&rdquo; a position it reiterated in last week&rsquo;s announcement. Xiao was detained on Sept. 6 in Dandong, a city in Northeast China&rsquo;s Liaoning province on the border with North Korea. The company has not provided any details about the nature of his suspected illegal activity that led to the detention.
Unlike CFOs at many young Chinese tech companies that often jump from firm to firm after just a few years at a company, Xiao, 55, has been with Transsion for a decade after joining in 2014. He and Transsion founder Zhu Zhaojiang previously worked at Ningbo Bird, one of China&rsquo;s early smartphone leaders. Beyond this basic information, details about Xiao&rsquo;s role in Transsion are scarce.
Despite Transsion&rsquo;s reassurances, investors were unsettled by the developments involving Xiao. When his detention was first announced, Transsion&rsquo;s stock plunged 8% when the market opened on Sept. 9 and later closed down 5%. The stock recovered following Xiao&rsquo;s release, but investor confidence towards the company remains fragile.
Transsion&rsquo;s shares have been on a downward trajectory since mid-April. Last Friday&rsquo;s closing price of 84 yuan is down more than 30% from the 120 yuan recorded in mid-April. While the stock trades on China&rsquo;s domestic A-shares market, it is also accessible to international investors through a program linking the Shanghai and Hong Kong stock exchanges.
Transsion currently trades at a price-to-earnings (P/E) ratio of 18, which is below the 24 for rival&nbsp;Xiaomi&nbsp;(1810.HK), which is also expanding into markets where Transsion operates. Both figures are significantly lower than&nbsp;Apple&rsquo;s&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) P/E ratio of 35, reflecting investors&rsquo; willingness to award higher valuations to premium market leaders with higher profit margins.
<h3>Mounting Challenges</h3>
Founded in 2006, Transsion started selling its smartphones in Africa, where it quickly gained prominence. Its Tecno, Itel, and Infinix brands have become household names across the continent. However, as market saturation and competition intensify there, Transsion has&nbsp;<a href="https://thebambooworks.com/transsion-climbs-global-smartphone-leader-board-with-its-move-out-of-africa/">started expanding</a>&nbsp;into other developing markets as well.
The company&rsquo;s revenue rose by 38% to 34.6 billion yuan ($4.9 billion) in the first half of this year, while its net profit increased by a similar 35.7% to 2.85 billion yuan, its latest financial results showed. The company attributed the strong performance to &ldquo;continuous expansion into emerging markets and advancement of product upgrades.&rdquo;
The highly competitive India market has been one of Transsion&rsquo;s recent focuses. Despite gradual gains since its relatively early entry there in 2015, the company is still trying to break into the top five vendors. Transsion has also been rapidly expanding into Southeast Asia, Eastern Europe, and Latin America. In Southeast Asia alone, it shipped 4.2 million smartphones in the first quart of 2024, triple its shipments a year earlier, according to Canalys..
Given those gains and its strong double-digit revenue and profit growth, why aren&rsquo;t investors more enthusiastic about this company? Two main reasons appear to underpin their concern. First, Transsion&rsquo;s low-end models typically have thin profit margins and rely on high-volume sales to boost profits. Its focus on such cheaper models has confined the company mostly to emerging markets, and kept it away from higher margin markets like Europe.
Transsion has also ventured into the relatively premium segment with models like the Tecno Phantom V Flip and Phantom V Fold, priced significantly higher than its traditional $100-$200 offerings. But that segment is also fiercely competitive, with rivals such as Xiaomi,&nbsp;Oppo, and&nbsp;Vivo&nbsp;already dominating markets like Southeast Asia and Latin America for such models.
The second, and perhaps more critical, reason for investor wariness is ongoing litigation against Transsion outside China. In July, U.S. chip giant Qualcomm filed lawsuits alleging patent infringement against the company and its subsidiaries in India, Germany, and other locations. All these cases are still pending.
A similar case involving Oppo highlights the negative impact such disputes can have on a company. In 2021, a Nokia lawsuit forced Oppo to withdraw from Germany entirely. Though Oppo later returned in 2023 after settling the lawsuit, its absence from one of Europe&rsquo;s largest markets cost it dearly in sales and market presence.
Transsion can hardly afford such setbacks and must continue proving it can gain market share in new regions to keep investors happy. At the same time, it can&rsquo;t neglect its African stronghold, especially as competitors like Xiaomi actively expand there. Its shipments in Africa grew by just 1% in the second quarter, while Xiaomi, realme, and Oppo grew by 45%, 137%, and 39%, respectively, according to Canalys.
The CFO crisis appears to be resolved by now, though it could still point to future legal issues for Transsion. At the same time, the ongoing patent lawsuits remain a major issue dogging the company. Addressing those concerns will be crucial for Transsion to keep up its momentum, as rivals like Xiaomi and Oppo nip at its heels in Africa and try to slow its rise in other emerging markets.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

AAPL

DOYU

Transsion Dodges Bullet With CFO's Release After Two-Week Detention

Melius Research analyst Karen Short initiates coverage on Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Hold rating and announces Price Target of $85.

Melius Research Initiates Coverage On Dollar Gen with Hold Rating, Announces Price Target of $85

Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares are trading lower on Monday. The company disclosed that its subsidiary, Bollinger Motors, achieved a milestone on September 20, 2024, by producing the first customer-ready <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40980994/mullen-subsidiary-bollinger-motors-achieves-major-milestone-today-with-production-of-first-custome" rel="noreferrer noopener">B4 electric truck in Livonia, Michigan</a>.
Bollinger Motors has partnered with Roush Industries for B4 production, utilizing Roush&#8217;s contract manufacturing services at its Livonia, Michigan facility.
This collaboration leverages Roush&#8217;s expertise in production and e-mobility, developed over 50 years of engineering, testing, prototyping, and manufacturing.
Bollinger, founder of Bollinger Motors said, &#8220;We&#8217;ve made an impact here in Detroit and I am proud of all the work this team has done to get to this day. We are launching a world-class electric truck that will be a leader in the commercial fleet business.&#8221;
Bollinger Motors&#8217; CEO Jim Taylor stated, &#8220;The commercial vehicle segment is ready for electrification and Bollinger Motors has developed a world-class truck that will meet the fleet needs for companies across the country. We are excited to see these vehicles roll off the line, head to dealer lots and find a home with our customers.&#8221;
Bollinger&#8217;s original vision in 2015 focused on launching high-end, all-electric pickup trucks and SUVs. However, recognizing that the electric SUV and pickup markets weren&#8217;t fully ready for consumers, Bollinger and his team pivoted in 2022 to develop the Class 4 all-electric truck, the Bollinger B4.
Notably, Bollinger Motors recently&nbsp;announced the&nbsp;2025 Bollinger B4 Chassis Cab electric truck will have a manufacturer&#8217;s <a target="_blank" href="https://www.benzinga.com/news/24/09/40921203/whats-happening-with-mullen-automotive-stock-after-reverse-split" rel="noreferrer noopener">suggested retail price (MSRP)&nbsp;of $158,758</a>.
Last week, the company announced an update on Volt Mobility&#8217;s recently placed $210 million commercial&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40961594/mullen-automotive-gears-up-210m-ev-deal-in-dubai-delivers-first-units-to-volt-mobility" rel="noreferrer noopener">Class 1 and Class 3 EV order in Dubai</a>.&nbsp;
Price Action: MULN shares are down 8.5% at $6.11&nbsp;at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/m-a/24/09/40983591/qualcomm-takeover-of-intel-is-logically-unlikely-in-face-of-regulatory-challenges-analyst-says" target="_blank" rel="noreferrer noopener">Qualcomm Takeover Of Intel Is &#8216;Logically Unlikely&#8217; In Face Of Regulatory Challenges, Analyst Says</a></li>
</ul>

Equities

Small Cap

MULN

Mullen Automotive's Bollinger Motors Powers Up: First Customer-Ready B4 Electric Truck Rolls Off The Line In Michigan

Melius Research analyst Karen Short initiates coverage on Grocery Outlet Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) with a Hold rating and announces Price Target of $17.

Melius Research Initiates Coverage On Grocery Outlet Holding with Hold Rating, Announces Price Target of $17

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Ventyx Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTYX#NASDAQ">VTYX</a>) with a Neutral and maintains $6 price target.

VTYX

HC Wainwright & Co. Reiterates Neutral on Ventyx Biosciences, Maintains $6 Price Target

ORGS

Orgenesis shares are trading lower after the company announced a 1-for-10 reverse stock split.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday!



Moving stocks are a new partnership, earnings, an acquisition deal and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>NLS Pharmaceutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nlsp-stock-quote/">NLSP</a>) stock is rocketing more than 156% alongside heavy pre-market trading.</li>



<li>Actelis Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/asns-stock-quote/">ASNS</a>) shares are soaring over 137% after <a href="https://finance.yahoo.com/news/actelis-partners-carahsoft-major-us-203000611.html">announcing a new partnership</a> with Carahsoft.</li>



<li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock is surging more than 25% despite a lack of news this morning.</li>



<li>Silk Road Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/silk-stock-quote/">SILK</a>) shares are increasing over 23% <a href="https://www.nasdaq.com/press-release/boston-scientific-announces-agreement-acquire-silk-road-medical-inc-2024-06-18">on an acquisition agreement</a>.</li>



<li>Mustang Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/mbio-stock-quote/">MBIO</a>) stock is gaining more than 22% as it <a href="https://investorplace.com/2024/06/why-is-mustang-bio-mbio-stock-up-347-today/">continues a clinical study rally</a>.</li>



<li>Fly-E Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/flye-stock-quote/">FLYE</a>) shares are rising over 21% after <a href="https://finance.yahoo.com/news/fly-e-group-inc-announces-191000159.html">going public earlier this month</a>.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) stock is heading more than 21% higher alongside its <a href="https://www.nasdaq.com/press-release/sonoma-pharmaceuticals-reports-fiscal-year-and-fourth-quarter-2024-financial-results">Q4 earnings report</a>.</li>



<li>Clene (NASDAQ:<a href="https://investorplace.com/stock-quotes/clnn-stock-quote/">CLNN</a>) shares are climbing over 18% higher on <a href="https://www.nasdaq.com/press-release/clene-presents-extended-survival-data-through-35-years-and-new-nfl-responder-results">extended survival data</a>.</li>



<li>Chegg (NYSE:<a href="https://investorplace.com/stock-quotes/chgg-stock-quote/">CHGG</a>) stock is jumping 18% on <a href="https://finance.yahoo.com/news/chegg-announces-restructuring-plan-vision-203500268.html">job cuts and a restructuring plan</a>.</li>



<li>BioLine Rx (NASDAQ:<a href="https://investorplace.com/stock-quotes/blrx-stock-quote/">BLRX</a>) shares are up more than 17% without any clear news this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Aerwins Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/awin-stock-quote/">AWIN</a>) stock is crashing over 52% as its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318398965&amp;type=PDF&amp;symbol=AWIN&amp;cdn=c72eb168f714d139854f27235d706f2c&amp;companyName=AERWINS+Technologies+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-17">shares will be delisted today</a>.</li>



<li>Quantum (NASDAQ:<a href="https://investorplace.com/stock-quotes/qmco-stock-quote/">QMCO</a>) shares are plummeting more than 41% with the release of its <a href="https://www.nasdaq.com/press-release/quantum-reports-fiscal-full-year-2024-financial-results-2024-06-17">latest earnings report</a>.</li>



<li>Biolase (NASDAQ:<a href="https://investorplace.com/stock-quotes/biol-stock-quote/">BIOL</a>) stock is diving over 39% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318400377&amp;type=PDF&amp;symbol=BIOL&amp;cdn=37ce2e9246b65a79c01aa57fdd1c4b39&amp;companyName=Biolase+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-18">on a delisting notice</a>.</li>



<li>Connexa Sports Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/yyai-stock-quote/">YYAI</a>) shares are tumbling more than 23% on plans for a <a href="https://www.nasdaq.com/press-release/connexa-applies-imminent-1-20-reverse-split-remedy-bid-price-delisting-notice-2024-06">reverse stock split to avoid delisting</a>.</li>



<li>Interactive Strength (NASDAQ:<a href="https://investorplace.com/stock-quotes/trnr-stock-quote/">TRNR</a>) stock is taking an over 22% beating <a href="https://investorplace.com/2024/06/interactive-strength-trnr-stock-surges-129-after-reverse-stock-split/">after rallying yesterday</a>.</li>



<li>Srivaru (NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/">SVMH</a>) shares are sliding more than 15% as it <a href="https://investorplace.com/2024/06/why-is-srivaru-svmh-stock-up-122-today/">retreats from a recent rally</a>.</li>



<li>Virpax Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrpx-stock-quote/">VRPX</a>) stock is dropping over 15% on Tuesday morning.</li>



<li>Bio-Path (NASDAQ:<a href="https://investorplace.com/stock-quotes/bpth-stock-quote/">BPTH</a>) shares are decreasing more than 14% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318397757&amp;type=PDF&amp;symbol=BPTH&amp;cdn=71f3deb6bebaba5ab0528b1ade5a312b&amp;companyName=Bio-Path+Holdings+Inc.&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-06-17">secondary stock offering</a>.</li>



<li>Anitra (NYSEMKT:<a href="https://investorplace.com/stock-quotes/aztr-stock-quote/">AZTR</a>) stock is falling over 14% today.</li>



<li>Kineta (NASDAQ:<a href="https://investorplace.com/stock-quotes/ka-stock-quote/">KA</a>) shares close out our pre-market stock movers down more than 12% this morning.</li>
</ol><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-june-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth keeping an eye on and we have a breakdown of all the biggest ones to watch on Friday!



Moving stocks are mergers, clinical trial data, public offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Crown LNG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) stock is rocketing almost 154% after <a href="https://finance.yahoo.com/news/crown-lng-holding-announces-completion-201700767.html">recently completing a business combination</a>.</li>



<li>Toyo (NASDAQ:<a href="https://investorplace.com/stock-quotes/toyo-stock-quote/">TOYO</a>) shares are soaring close to 111% alongside heavy pre-market trading.</li>



<li>Sentage (NASDAQ:<a href="https://investorplace.com/stock-quotes/sntg-stock-quote/">SNTG</a>) stock is surging over 60% with strong early morning trading.</li>



<li>Above Food Ingredients (NASDAQ:<a href="https://investorplace.com/stock-quotes/abve-stock-quote/">ABVE</a>) shares are increasing more than 42% without any clear news this morning.</li>



<li>Monterey Capital Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcac-stock-quote/">MCAC</a>) stock is gaining over 23% on Friday morning.</li>



<li>Maxeon Solar Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/">MAXN</a>) shares are rising more than 19% with heavy early morning trading.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) stock is heading nearly 16% higher with strong pre-market trading.</li>



<li>Immutep (NASDAQ:<a href="https://investorplace.com/stock-quotes/immp-stock-quote/">IMMP</a>) shares are climbing over 15% with <a href="https://www.nasdaq.com/market-activity/stocks/immp/press-releases">positive clinical results</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) stock is jumping more than 14% on Friday.</li>



<li>Instil Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/til-stock-quote/">TIL</a>) shares are up over 14% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Shineco (NASDAQ:<a href="https://investorplace.com/stock-quotes/sisi-stock-quote/">SISI</a>) stock is crashing more than 44% on a <a href="https://www.nasdaq.com/press-release/shineco-announces-proposed-underwritten-public-offering-2024-07-11">proposed public offering</a>.</li>



<li>ASP Isotopes (NASDAQ:<a href="https://investorplace.com/stock-quotes/aspi-stock-quote/">ASPI</a>) shares are diving over 19% as it also announces a <a href="https://www.globenewswire.com/news-release/2024/07/11/2912107/0/en/ASP-Isotopes-Announces-Proposed-Public-Offering-of-Common-Stock.html">proposed public offering</a>.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) stock is tumbling 18% following a <a href="https://www.nasdaq.com/press-release/more-1bn-annual-sales-alta-equipment-group-joins-cyngns-dealer-network-2024-07-11">massive rally yesterday</a>.</li>



<li>Kazia Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kzia-stock-quote/">KZIA</a>) shares are retreating more than 16% <a href="https://investorplace.com/2024/07/kzia-stock-alert-kazia-continues-its-surge-on-thursday-with-51-gains/">after rallying this week</a>.</li>



<li>Nano Nuclear Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/nne-stock-quote/">NNE</a>) stock is taking an over 12% beating after <a href="https://www.nasdaq.com/press-release/nano-nuclear-energy-announces-pricing-upsized-18-million-underwritten-offering-2024">pricing an upsized underwritten offering</a>.</li>



<li>Biodexa Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/bdrx-stock-quote/">BDRX</a>) shares are falling more than 10% after jumping yesterday on <a href="https://seekingalpha.com/news/4123698-biodexa-stock-rallies-amid-release-of-phase-2-data-for-erapa">clinical trial data</a>.</li>



<li>Digital Brands Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/dbgi-stock-quote/">DBGI</a>) stock is dropping over 10% this morning.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) shares are decreasing more than 10% following a Thursday rally.</li>



<li>Forward Industries (NASDAQ:<a href="https://investorplace.com/stock-quotes/ford-stock-quote/">FORD</a>) stock is dipping 10% without any news to report.</li>



<li>Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) shares close out our pre-market stock movers down over 9% this morning.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-12th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic as we dive into all of the biggest news traders need to know about on Monday morning!



Moving stocks this morning are an acquisition deal, a strategic alliance, earnings data and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Tellurian (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tell-stock-quote/">TELL</a>) stock is rocketing more than 66% <a href="https://finance.yahoo.com/news/tellurian-acquired-woodside-approximately-900-222900949.html">due to a $900 million acquisition deal</a>.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) shares are soaring over 60% after Nvidia (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>) <a href="https://investorplace.com/2024/07/serv-stock-soars-as-nvidia-reveals-big-bet-on-serve-robotics/">revealed a stake in the company</a>.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) stock is surging more than 56% after <a href="https://www.nasdaq.com/press-release/castellum-inc-announces-strategic-alliance-k2-2024-07-22">announcing a strategic alliance</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares are rising over 40% alongside heavy pre-market trading.</li>



<li>Richtech Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rr-stock-quote/">RR</a>) stock is increasing more than 27% after <a href="https://www.nasdaq.com/press-release/richtech-robotics-celebrates-completion-installation-adam-ghost-kitchens-inside">adding ADAM to certain ghost kitchens</a>.</li>



<li>CISO Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/ciso-stock-quote/">CISO</a>) shares are gaining over 24% after announcing <a href="https://www.nasdaq.com/press-release/ciso-global-announces-solution-mitigate-impact-crowdstrike-security-event-2024-07-19">a way to mitigate damage</a> from the CrowdStrike (NASDAQ:<a href="https://investorplace.com/stock-quotes/crwd-stock-quote/">CRWD</a>) issues last week.</li>



<li>Tellurian Inc. 8.25% Senior Notes due 2028 (NYSEMKT:<a href="https://investorplace.com/stock-quotes/telz-stock-quote/">TELZ</a>) are heading more than 21% higher this morning.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) stock is climbing over 18% without any clear news this morning.</li>



<li>Society Pass (NASDAQ:<a href="https://investorplace.com/stock-quotes/sopa-stock-quote/">SOPA</a>) shares are jumping more than 17% on Monday morning.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is up over 16% without any clear news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is plummeting more than 24% after a major rally on Friday.</li>



<li>Sentage (NASDAQ:<a href="https://investorplace.com/stock-quotes/sntg-stock-quote/">SNTG</a>) shares are diving over 14% on Monday morning.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) stock is tumbling close to 14% this morning.</li>



<li>Novo Integrated Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvos-stock-quote/">NVOS</a>) shares are taking a nearly 14% beating after <a href="https://investorplace.com/earning-results/2024/07/nvos-stock-earnings-novo-integrated-sciences-for-q3-of-2024/">jumping Friday on earnings</a>.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) stock is sliding over 13% on Monday morning.</li>



<li>Ryanair (NASDAQ:<a href="https://investorplace.com/stock-quotes/ryaay-stock-quote/">RYAAY</a>) shares are falling more than 13% alongside <a href="https://www.cnbc.com/2024/07/22/ryanair-q1-2024-results-shares-fall-on-lower-fares-fall-in-quarterly-profit.html">falling quarterly profit</a>.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) stock is dropping over 11% on Monday.</li>



<li>Stronghold Digital Mining (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdig-stock-quote/">SDIG</a>) shares are decreasing more than 11% this morning.</li>



<li>60 Degrees (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) stock is slipping over 10% on Monday morning.</li>



<li>PS International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) shares close out our pre-market stock movers down almost 10% on Monday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Sonoma Pharmaceuticals reports Q1 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) just reported results for the first quarter of 2025.<ul><li>Sonoma Pharmaceuticals reported earnings per share of -7 cents. This was below the analyst estimate for EPS of -6 cents.</li><li>The company reported revenue of $3.39 million.</li><li>This was 13.93% worse than the analyst estimate for revenue of $3.94 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/snoa-stock-earnings-sonoma-pharmaceuticals-for-q1-of-2025/">SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!



Moving stocks are new patents, insider buying, a company name change and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>PS International Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/psig-stock-quote/">PSIG</a>) stock is rocketing more than 81% alongside heavy pre-market trading.</li>



<li>Ainos (NASDAQ:<a href="https://investorplace.com/stock-quotes/aimd-stock-quote/">AIMD</a>) shares are soaring over 47% after <a href="https://www.nasdaq.com/press-release/ainos-secures-exclusive-multi-regions-invention-patent-licenses-strategic-partner">securing new patent licenses</a>.</li>



<li>LogicMark (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgmk-stock-quote/">LGMK</a>) stock is surging more than 38% alongside details of an upcoming <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318511278&amp;type=PDF&amp;symbol=LGMK&amp;cdn=5653ec5b97d2382396937934a20579e2&amp;companyName=LogicMark+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-08-09">special shareholder meeting</a>.</li>



<li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) shares are gaining over 25% despite a lack of news this morning.</li>



<li>Genius (NYSEMKT:<a href="https://investorplace.com/stock-quotes/gns-stock-quote/">GNS</a>) stock is increasing more than 19% <a href="https://www.nasdaq.com/press-release/genius-group-founder-ceo-roger-james-hamilton-purchase-10-million-shares-2024-08-09">on insider buying</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) shares are rising over 19% on <a href="https://www.nasdaq.com/press-release/fsd-pharma-announces-share-consolidation-and-name-change-2024-08-09">share consolidation and name change plans</a>.</li>



<li>ProMIS Neurosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/pmn-stock-quote/">PMN</a>) stock is climbing more than 17% this morning.</li>



<li>ConnectM Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/cntm-stock-quote/">CNTM</a>) shares are heading over 17% higher without any clear news today.</li>



<li>BioVie (NASDAQ:<a href="https://investorplace.com/stock-quotes/bivi-stock-quote/">BIVI</a>) stock is jumping more than 15% on Monday morning.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) shares are up over 14% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>iLearningEngines (NASDAQ:<a href="https://investorplace.com/stock-quotes/aile-stock-quote/">AILE</a>) stock is plummeting more than 27% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318511870&amp;type=PDF&amp;symbol=AILE&amp;cdn=8f0ca76b44522478ea48d6b3e52f5445&amp;companyName=iLearningEngines+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-08-09">pricing a public offering</a>.</li>



<li>Meta Materials (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmat-stock-quote/">MMAT</a>) shares are diving over 17% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318508874&amp;type=PDF&amp;symbol=MMAT&amp;cdn=747b3fffafae953c1fe1c54f998009fd&amp;companyName=Meta+Materials+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-08-09">filing for bankruptcy</a>.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) stock is tumbling more than 15% after <a href="https://finance.yahoo.com/news/sonoma-pharmaceuticals-first-quarter-2025-120225512.html">missing fiscal Q1 2025 earnings estimates</a>.</li>



<li>Tenon Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnon-stock-quote/">TNON</a>) shares are taking an over 15% beating despite any clear news this morning.</li>



<li>Humacyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/huma-stock-quote/">HUMA</a>) stock is sliding more than 13% <a href="https://www.stocktitan.net/news/HUMA/humacyte-announces-fda-communication-of-additional-time-required-to-5oxy7ry3qlgj.html">on an update</a> from the Food and Drug Administration (FDA).</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are falling over 12% on a <a href="https://www.nasdaq.com/press-release/aditxt-announces-12-million-registered-direct-offering-priced-market-under-nasdaq">registered direct offering</a>.</li>



<li>CareMax (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmax-stock-quote/">CMAX</a>) stock is dropping close to 12% on a <a href="https://finance.yahoo.com/news/caremax-inc-cmax-reports-q2-224503059.html">Q2 loss and revenue miss</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) shares are decreasing more than 10% <a href="https://www.nasdaq.com/press-release/big-tree-cloud-holdings-limited-receives-nasdaq-notification-regarding-minimum-market">with a delisting notice</a>.</li>



<li>Azitra&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/aztr-stock-quote/">AZTR</a>) stock is slipping over 10% this morning.</li>



<li>Bright Minds Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/drug-stock-quote/">DRUG</a>) shares close out our pre-market stock movers down more than 10% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-aug-12th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Sonoma Pharmaceuticals to implement a reverse stock split

Sonoma Pharmaceuticals (SNOA) has shared an update. During the adjourned annual meeting on August 23, 2024, Sonoma Pharmaceuticals, Inc.'s stockhol...

Sonoma Pharmaceuticals Stockholders Decide on Key Governance Issues

Sonoma and EMC to co-market an expanded eye care product line

Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule

ABVE

ADTX

ASNS

ASPI

AWIN

AZTR

BDRX

BIOL

BIVI

BLRX

BPTH

CGBS

CHGG

CISO

CLNN

CNTM

DBGI

DRUG

FLYE

FORD

IMMP

KZIA

MAXN

MBIO

MCAC

MLGO

NLSP

NUWE

NUZE

NVDA

NVOS

QLGN

QMCO

SDIG

SILK

SISI

SNTG

SVMH

SXTP

TELZ

TOYO

TRNR

VRPX

VSME

YYAI

Contracts

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Sonoma Pharmaceuticals

Sonoma Pharmaceuticals (SNOA) Forecast

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock, Quote.Headers.trade-ideas